DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 55 · November 2022 DOI: 10.1055/s-012-55605


Abstracts of the 3rd Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Berlin, Germany, 12.–14.09.2022

Editors:
Frank Faltraco, Rostock, Germany
Manfred Gerlach,Würzburg, Germany
Abstracts (HTML) Abstracts (PDF) Autorenliste

Original Paper

281
Aguglia, Andrea; Fusar-Poli, Laura; Natale, Antimo; Amerio, Andrea; Espa, Irene; Villa, Veronica; Martinotti, Giovanni; Carrà, Giuseppe; Bartoli, Francesco; D’Agostino, Armando; Serafini, Gianluca; Amore, Mario; Aguglia, Eugenio; Ostuzzi, Giovanni; Barbui, Corrado: Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study
291
Kishi, Taro; Sakuma, Kenji; Iwata, Nakao: Aripiprazole Once-Monthly Versus Oral Aripiprazole for Schizophrenia in the Maintenance Phase: A Systematic Review and Network Meta-Analysis
Supplementary Material
297
Kim, Helena K.; Zai, Gwyneth; Müller, Daniel J.; Husain, Muhammad I.; Lam, Raymond W.; Frey, Benicio N.; Soares, Claudio N.; Parikh, Sagar V.; Milev, Roumen; Foster, Jane A.; Turecki, Gustavo; Farzan, Faranak; Mulsant, Benoit H.; Kennedy, Sidney H.; Tripathy, Shreejoy J.; Kloiber, Stefan: Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study
Supplementary Material

Letter to the Editor

305
Papadopoulos, Konstantinos I.; Papadopoulou, Alexandra; Aw, Tar-Choon: Selective Serotonin Reuptake Inhibitors may Influence COVID-19 Prognosis through Antioxidant and Cytoprotective Pathways Mediated by Sigma 1 Receptor Agonism